This often leads to overexpression of membrane serine protease fibroblast activating protein alpha (FAP-α, also known as prolyl endopeptidase FAP), which is estimated to be overexpressed in approximately 90% of human cancers [2–4]. The gene discussed is FAP; the disease is cancer.